CELL-MEDIATED CYTOTOXICITY

CELL-MEDIATED CYTOTOXICITY was reported 51 times

CELL-MEDIATED CYTOTOXICITY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD22-directed Immunoconjugate [EPC] 3 0.0010
1 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 8 0.0004
2 SLAMF7-directed Immunostimulatory Antibody [EPC] 1 0.0002
3 Antimycobacterial [EPC] 3 0.0001
4 CD19-directed Chimeric Antigen Receptor [EPC] 1 0.0001
5 Antimalarial [EPC] 1 0.0001
6 Antiprotozoal [EPC] 1 0.0001
7 Rifamycin Antibacterial [EPC] 3 0.0001
8 HER2/neu Receptor Antagonist [EPC] 5 0.0001
9 Antirheumatic Agent [EPC] 7 0.0001
10 Topoisomerase Inhibitor [EPC] 4 0.0001
11 Microtubule Inhibitor [EPC] 7 0.0000
12 Nucleoside Metabolic Inhibitor [EPC] 9 0.0000
13 General Anesthetic [EPC] 1 0.0000
14 Alkylating Drug [EPC] 5 0.0000
15 Folate Analog Metabolic Inhibitor [EPC] 9 0.0000
16 Macrolide Antimicrobial [EPC] 1 0.0000
17 BCL-2 Inhibitor [EPC] 1 0.0000
18 Mood Stabilizer [EPC] 3 0.0000
19 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
20 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
21 Proteasome Inhibitor [EPC] 1 0.0000
22 Corticosteroid [EPC] 11 0.0000
23 Fluoroquinolone Antibacterial [EPC] 1 0.0000
24 Platinum-based Drug [EPC] 2 0.0000
25 Osmotic Laxative [EPC] 2 0.0000
26 Azole Antifungal [EPC] 1 0.0000
27 Janus Kinase Inhibitor [EPC] 1 0.0000
28 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
29 Kinase Inhibitor [EPC] 3 0.0000
30 Tumor Necrosis Factor Blocker [EPC] 4 0.0000
31 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
32 Benzodiazepine [EPC] 2 0.0000
33 Platelet Aggregation Inhibitor [EPC] 1 0.0000
34 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000